Benchling, which offers a software suite for improving collaboration and productivity among life sciences and biotech researchers, has raised $14.5 million in series B funding. Benchmark led the round, with additional participation by F-Prime Capital and returning investor Thrive Capital.

from MobiHealthNews https://ift.tt/2lcXDuQ

Related Posts:

0 comments:

Post a Comment

Popular Posts